Cynosure to develop products with Unilever
This article was originally published in The Rose Sheet
Executive Summary
Cynosure, a developer of light-based aesthetic treatment systems, signs a multi-year, funded cooperative agreement with Unilever to develop and market light-based devices for consumer use at home, firms announce July 1. Deal will allow for the development of products to target "multiple benefit areas," though initial focus will be on creating a skin rejuvenation product. "One of our long-term corporate objectives has been to enter the emerging home-use [device] market, and Unilever represents an ideal partner for us," says Cynosure President and Chief Executive Officer Michael Davin. "We view this agreement as a first step in forming a meaningful long-term strategic relationship with Unilever." Unilever's Genevieve Beger, chief research and development officer, identifies emerging market for home-use light-based products as a "promising long-term opportunity.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.